Status:
UNKNOWN
Preoperative Prophylactic Antibiotic Duration in Moderate to High Risk Ureteroscopy
Lead Sponsor:
University of California, San Francisco
Conditions:
Infections, Urinary Tract
Nephrolithiasis
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
The goal of this non-inferiority randomized controlled trial: is to test the hypothesis that the that there is no additional benefit from a longer course (7 days) versus a shorter course (2 days) of p...
Detailed Description
Post-operative infectious complications including urinary tract infection (UTI), systemic inflammatory response syndrome (SIRS), and sepsis are uncommon but potentially devastating complications after...
Eligibility Criteria
Inclusion
- age (greater than or equal to 18 years)
- indwelling ureteral stent in place
- nephrostomy tube in place
- indwelling foley catheter, suprapubic catheter or clean intermittent catheterization
- asymptomatic bacteriuria
- bowel interposition (such as ileal conduit, neobladder)
- immunosuppression (such as for transplant recipients, active chemotherapy use)
Exclusion
- pregnancy
- active infection
- received antibiotics within 7 days preceding surgery that were not prescribed for the study
Key Trial Info
Start Date :
January 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT06149455
Start Date
January 1 2024
End Date
January 1 2026
Last Update
December 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Francisco
San Francisco, California, United States, 94143